EP4 Receptor–Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis
Inflammatory bowel disease (IBD) is one of the most prevalent and serious gastrointestinal diseases in Western countries and associates with cancer development. EP4 receptor signaling can suppress intestinal inflammation and shows promise as a target for the development of novel therapies for IBD. To date, however, the lack of detailed molecular targets has hampered the development of effective drugs. This study focused on EPRAP, a novel EP4 receptor–associated protein, implicated in its signaling pathway. The generation of EPRAP-gene mutated mice permitted exploration of EPRAP functions in vivo. In addition, EPRAP was localized in stromal macrophages of ulcerative colitis patients. This study revealed that EPRAP in macrophage participates critically in EP4 receptor signaling-mediated inhibition of intestinal inflammation. The macrophage EP4–EPRAP axis thus comprises a novel therapeutic target for IBD.
Vyšlo v časopise:
EP4 Receptor–Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis. PLoS Genet 11(10): e32767. doi:10.1371/journal.pgen.1005542
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1005542
Souhrn
Inflammatory bowel disease (IBD) is one of the most prevalent and serious gastrointestinal diseases in Western countries and associates with cancer development. EP4 receptor signaling can suppress intestinal inflammation and shows promise as a target for the development of novel therapies for IBD. To date, however, the lack of detailed molecular targets has hampered the development of effective drugs. This study focused on EPRAP, a novel EP4 receptor–associated protein, implicated in its signaling pathway. The generation of EPRAP-gene mutated mice permitted exploration of EPRAP functions in vivo. In addition, EPRAP was localized in stromal macrophages of ulcerative colitis patients. This study revealed that EPRAP in macrophage participates critically in EP4 receptor signaling-mediated inhibition of intestinal inflammation. The macrophage EP4–EPRAP axis thus comprises a novel therapeutic target for IBD.
Zdroje
1. Khor B, Gardet A, & Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474(7351):307–317. doi: 10.1038/nature10209 21677747
2. Narumiya S, Sugimoto Y, & Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiological reviews 79(4):1193–1226. 10508233
3. Bjarnason I, et al. (1989) Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Digestive diseases and sciences 34(3):407–411. 2493366
4. Tessner TG, Cohn SM, Schloemann S, & Stenson WF (1998) Prostaglandins prevent decreased epithelial cell proliferation associated with dextran sodium sulfate injury in mice. Gastroenterology 115(4):874–882. 9753490
5. Kabashima K, et al. (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. The Journal of clinical investigation 109(7):883–893. 11927615
6. Rostom A, et al. (2002) Prevention of NSAID-induced gastroduodenal ulcers. Cochrane database of systematic reviews (4):CD002296. 12519573
7. Audoly LP, et al. (1999) Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. The American journal of physiology 277(3 Pt 2):H924–930. 10484412
8. Nakase H, et al. (2010) Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. Inflammatory bowel diseases 16(5):731–733. doi: 10.1002/ibd.21080 19760781
9. Takayama K, Sukhova GK, Chin MT, & Libby P (2006) A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling. Circulation research 98(4):499–504. 16424369
10. Krakow D, Sebald E, King LM, & Cohn DH (2001) Identification of human FEM1A, the ortholog of a C. elegans sex-differentiation gene. Gene 279(2):213–219. 11733146
11. Spence AM, Coulson A, & Hodgkin J (1990) The product of fem-1, a nematode sex-determining gene, contains a motif found in cell cycle control proteins and receptors for cell-cell interactions. Cell 60(6):981–990. 2317869
12. Minami M, et al. (2008) Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. The Journal of biological chemistry 283(15):9692–9703. doi: 10.1074/jbc.M709663200 18270204
13. Okayasu I, et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98(3):694–702. 1688816
14. Williams KL, et al. (2001) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120(4):925–937. 11231946
15. Rutter M, et al. (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126(2):451–459. 14762782
16. Coussens LM & Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867. 12490959
17. Naito Y, Takagi T, & Yoshikawa T (2007) Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. Journal of gastroenterology 42(10):787–798. 17940831
18. Takafuji V, Cosme R, Lublin D, Lynch K, & Roche JK (2000) Prostanoid receptors in intestinal epithelium: selective expression, function, and change with inflammation. Prostaglandins, leukotrienes, and essential fatty acids 63(4):223–235. 11049698
19. Eberhart CE & Dubois RN (1995) Eicosanoids and the gastrointestinal tract. Gastroenterology 109(1):285–301. 7797026
20. Harizi H, Grosset C, & Gualde N (2003) Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. Journal of leukocyte biology 73(6):756–763. 12773508
21. Belich MP, Salmeron A, Johnston LH, & Ley SC (1999) TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105. Nature 397(6717):363–368. 9950430
22. Gantke T, Sriskantharajah S, Sadowski M, & Ley SC (2012) IkappaB kinase regulation of the TPL-2/ERK MAPK pathway. Immunological reviews 246(1):168–182. doi: 10.1111/j.1600-065X.2012.01104.x 22435554
23. Lawrenz M, et al. (2012) Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease? Mucosal immunology 5(2):129–139. doi: 10.1038/mi.2011.57 22157885
24. Erdman S, Fox JG, Dangler CA, Feldman D, & Horwitz BH (2001) Typhlocolitis in NF-kappa B-deficient mice. Journal of immunology 166(3):1443–1447.
25. Visekruna A, et al. (2006) Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. The Journal of clinical investigation 116(12):3195–3203. 17124531
26. Hibi T, Ueno F, Matsuoka K, Lee TC, Research Group for Intractable Inflammatory Bowel Disease 2006 Guidelines for the management of ulcerative colitis in Japan-Developed through integration of evidence and consensus among experts-. IBD Research 4: 189–239.
27. Weigmann B, et al. (2007) Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nature protocols 2(10):2307–2311. 17947970
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2015 Číslo 10
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Single Strand Annealing Plays a Major Role in RecA-Independent Recombination between Repeated Sequences in the Radioresistant Bacterium
- The Rise and Fall of an Evolutionary Innovation: Contrasting Strategies of Venom Evolution in Ancient and Young Animals
- Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross
- DCA1 Acts as a Transcriptional Co-activator of DST and Contributes to Drought and Salt Tolerance in Rice